OpenAlex
PricingAboutJobs
Log inGet started
Work

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

HTML

Year: 2017
Type: article
Study design: Case Report
Source: Journal of the American Academy of Dermatology
DOI: 10.1016/j.jaad.2017.05.043
Authors: Lucy Y. Liu, James P. Strassner, Maggi A. Refat, John E. Harris, Brett A. King
Institutions: Yale University, University of Massachusetts Chan Medical School
Language: English

Topic: melanin and skin pigmentation
Subfield: Cell Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: vitiligo, tofacitinib, JAK inhibitors, repigmentation, narrowband UVB phototherapy, sun exposure, melanocyte regeneration, autoimmunity, T cell-mediated autoimmunity
SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Center for Advancing Translational Sciences
Awards: University of Massachusetts Center for Clinical and Translational Science, Treg Migration and Function During Autoimmunity within Peripheral Tissue, Innate Immunity Training Program
OpenAlex ID: W2746940679
FWCI: 7.249
Cites: 27
Cited by: 264
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms